Jessica Zhang, MD
Anesthesiology · Federal Way
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- University of Connecticut School of Medicine, 2016
Offices
1 location · Kaiser Foundation Health Plan of Washington · 1,519 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Zhang’s office at (253) 874-7000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A174091 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · University of Connecticut School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,460
Medicare paid this office $1,460 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 19 | 20 | – | – |
| Injection of trigger points, 1-2 muscles | – | 24 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 67 · Health risk score 2.02. Above the middle of the specialty; the typical anesthesiology clinician is at 1.54.
The office billed $3,022, Medicare allowed $1,973 and paid $1,460; for 15 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 15 | 67 | 2.02 | $3,022 | $1,460 |
| 2023 | 146 | 495 | 76 | 1.27 | $50,726 | $21,644 |
| 2022 | 330 | 2,405 | 74 | 1.08 | $550,585 | $129,961 |
| 2021 | 97 | 380 | 70 | 1.18 | $237,265 | $31,164 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 46 | $6,748 | $44 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 65 | $3,565 | $36 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 39 | $2,832 | $34 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 43 | $2,517 | $47 |
| Short return visit (20+ min) | 30 | $1,533 | $45 |
| Return visit (30+ min) | 15 | $1,445 | $80 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 11 | $538 | $41 |
2022: 18 services
| Return visit (30+ min) | 155 | $33,402 | $106 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 85 | $19,744 | $34 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 69 | $18,097 | $56 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 107 | $18,050 | $39 |
| Short return visit (20+ min) | 99 | $9,029 | $73 |
| New patient visit (45+ min) | 46 | $6,662 | $145 |
| Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | 32 | $3,027 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $2,875 | $76 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 17 | $2,445 | $122 |
| New patient visit (30+ min) | 21 | $1,941 | $92 |
| Administration of psychological or neuropsychological test, first 30 minutes | 42 | $1,939 | $43 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,576 | $143 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 60 | $1,092 | $18 |
| Injection of trigger points, 1-2 muscles | 13 | $1,063 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $595 | $50 |
| Assessment of emotional or behavioral problems | 27 | $119 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $94 | None |
| Insertion of needle into vein for collection of blood sample | 25 | $76 | $3 |
2021: 9 services
| Return visit (30+ min) | 60 | $13,481 | $126 |
| New patient visit (45+ min) | 16 | $2,562 | $160 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 17 | $2,483 | $131 |
| Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic co | 21 | $2,050 | $85 |
| Short return visit (20+ min) | 16 | $1,597 | $89 |
| Administration of psychological or neuropsychological test, first 30 minutes | 21 | $1,064 | $46 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 12 | $905 | $45 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 16 | $642 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $35 | None |
Medicaid work
$754 in 2023
Medicaid paid $754 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 13 | $754 |
| 2023 | 13 | 1 | 13 | $754 |
Drugs they prescribed that Part D paid
$754
Pharmacies billed $754 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
45 generic and fewer than 11 brand-name prescriptions · $754 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 14 | $151 | $11 |
Year by year
| 2024 | 47 | 31 | None | None | $754 |
| 2023 | 646 | 197 | None | None | $51,994 |
| 2022 | 1,228 | 238 | 10% (119) | None | $90,457 |
| 2021 | 369 | 132 | 30% (110) | None | $14,810 |
| 2020 | 95 | 58 | 21% (20) | None | $4,244 |
| 2017 | 60 | None | None | 23% | $508 |
| 2016 | 15 | None | None | None | $101 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Gabapentin | 43 | $576 | $13 |
| Metoprolol | 19 | $453 | $24 |
| Pregabalin | 25 | $376 | $15 |
| Atorvastatin | 37 | $336 | $9 |
| Duloxetine | 16 | $296 | $19 |
| Levothyroxine | 21 | $270 | $13 |
| Simvastatin | 26 | $248 | $10 |
| Trazodone | 11 | $217 | $20 |
| Lisinopril | 25 | $153 | $6 |
| Amlodipine Besylate | 21 | $153 | $7 |
| Sertraline | 16 | $142 | $9 |
| Metformin | 16 | $112 | $7 |
| Hydrochlorothiazide | 18 | $43 | $2 |
2022: 30 drugs
| Eliquis | 18 | $14,742 | $819 |
| Buprenorphine-Naloxone | 16 | $2,312 | $145 |
| Hydrocodone-Acetaminophen | 62 | $1,816 | $29 |
| Metoprolol | 30 | $1,073 | $36 |
| Duloxetine | 11 | $1,063 | $97 |
| Gabapentin | 67 | $1,014 | $15 |
| Trazodone | 27 | $588 | $22 |
| Atorvastatin | 55 | $588 | $11 |
| Levothyroxine | 34 | $546 | $16 |
| Oxycodone-Acetaminophen | 16 | $497 | $31 |
| Rosuvastatin | 12 | $433 | $36 |
| Alprazolam | 22 | $381 | $17 |
| Sertraline | 21 | $341 | $16 |
| Lisinopril | 41 | $266 | $6 |
| Simvastatin | 31 | $254 | $8 |
| Allopurinol | 14 | $242 | $17 |
| Oxycodone | 15 | $183 | $12 |
| Tamsulosin | 13 | $177 | $14 |
| Tizanidine | 12 | $173 | $14 |
| Cyclobenzaprine | 19 | $158 | $8 |
| Amlodipine Besylate | 26 | $146 | $6 |
| Losartan | 14 | $138 | $10 |
| Warfarin | 11 | $136 | $12 |
| Meloxicam | 12 | $122 | $10 |
| Hydrochlorothiazide | 32 | $113 | $4 |
| Metformin | 19 | $105 | $6 |
| Fluoxetine | 11 | $83 | $8 |
| Donepezil | 11 | $74 | $7 |
| Furosemide | 29 | $58 | $2 |
| Tramadol | 13 | $50 | $4 |
2021: 10 drugs
| Duloxetine | 28 | $1,170 | $42 |
| Hydrocodone-Acetaminophen | 32 | $1,080 | $34 |
| Gabapentin | 86 | $973 | $11 |
| Pregabalin | 13 | $710 | $55 |
| Tizanidine | 25 | $411 | $16 |
| Oxycodone-Acetaminophen | 16 | $257 | $16 |
| Oxycodone | 19 | $253 | $13 |
| Cyclobenzaprine | 11 | $251 | $23 |
| Diclofenac | 12 | $246 | $20 |
| Tramadol | 14 | $106 | $8 |
2020: 1 drug
| Gabapentin | 26 | $317 | $12 |
2017: 3 drugs
| Isosorbide Mononitrate Er | 11 | $81 | $7 |
| Clopidogrel | 11 | $41 | $4 |
| Lisinopril | 12 | $18 | $2 |
Money from drug and device companies
$126 in 2022
| 2022 | 6 | 7 | None | $126 |
| 2021 | 4 | 8 | None | $175 |
| 2020 | 1 | 1 | None | $95 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $29 | 2 payments
|
| Abbvie | Botox | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $20 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $18 | 1 payment
|
| Novo Nordisk | Rybelsus | $15 | 1 payment
|
See all 7 published payments
| Novo Nordisk | Meals · 2022-12-07 | Rybelsus | $15 |
| Janssen Pharmaceuticals | Meals · 2022-09-22 | Xarelto | $14 |
| Abbvie | Meals · 2022-08-16 | Botox | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2022-08-15 | Jardiance | $21 |
| Janssen Pharmaceuticals | Meals · 2022-07-28 | Xarelto | $16 |
| Stimwave Technologies | Meals · 2022-04-22 | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $20 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-04-21 | Nurtec Odt | $18 |
See earlier years (2021, 2020)
2021: $175
| Biohaven Pharmaceuticals | Nurtec Odt | $96 | 4 payments
|
| AbbVie | Qulipta | $41 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido | $20 | 1 payment
|
| Allergan | Botox | $17 | 1 payment
|
2020: $95
| Medtronic USA | Intellis | $95 | 1 payment
|
Professional record
- NPI
- 1437513447
- Licence
- CA 174091, NY 0905477, NY 303073California A174091: Current · expires 2027-07-31
- Trained
- University of Connecticut School of Medicine, 2016 · 10 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208VP0014X (208VP0014X); Federal specialty code 207L00000X (207L00000X); Federal specialty code 208VP0000X (208VP0000X)
- Mailing address
- 90 State St Ste 700ofc40, Albany, NY, 12207
- NPI first listed
- 2016-04-06
- NPI last updated
- 2023-06-13
- NPI record certified
- 2023-06-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1 Medical Center Dr, Lebanon, NH, 03756 · 1604 Blossom Hill Rd Ste 10, San Jose, CA, 95124
This office lists an electronic records connection.